HEMO.L
Price:
$1.37
Market Cap:
$18.38M
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal H...[Read more]
Industry
Biotechnology
IPO Date
2015-11-09
Stock Exchange
LSE
Ticker
HEMO.L
According to Hemogenyx Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current PE Ratio is -1.37. This represents a change of -99.97% compared to the average of -4515.65 of the last 4 quarters.
The mean historical PE Ratio of Hemogenyx Pharmaceuticals Plc over the last ten years is -41.00. The current -1.37 PE Ratio has changed 234.11% with respect to the historical average. Over the past ten years (40 quarters), HEMO.L's PE Ratio was at its highest in in the January 2015 quarter at 0. The PE Ratio was at its lowest in in the March 2017 quarter at -31249.91.
Average
-41.00
Median
-4.29
Minimum
-362.28
Maximum
-1.93
Discovering the peaks and valleys of Hemogenyx Pharmaceuticals Plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 290.93%
Maximum Annual PE Ratio = -1.93
Minimum Annual Increase = -99.28%
Minimum Annual PE Ratio = -362.28
Year | PE Ratio | Change |
---|---|---|
2023 | -3.88 | 30.02% |
2022 | -2.99 | 54.77% |
2021 | -1.93 | -89.81% |
2020 | -18.92 | 290.93% |
2019 | -4.84 | -5.43% |
2018 | -5.12 | 85.77% |
2017 | -2.76 | -41.39% |
2016 | -4.70 | 79.15% |
2015 | -2.62 | -99.28% |
The current PE Ratio of Hemogenyx Pharmaceuticals Plc (HEMO.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.93
5-year avg
-6.51
10-year avg
-41.00
Hemogenyx Pharmaceuticals Plc’s PE Ratio is less than Omega Diagnostics Group PLC (-1.25), less than genedrive plc (-0.61), greater than Avacta Group Plc (-6.60), less than Novacyt S.A. (-1.03), greater than Synairgen plc (-2.59),
Company | PE Ratio | Market cap |
---|---|---|
-1.25 | $4.94M | |
-0.61 | $12.85M | |
-6.60 | $191.25M | |
-1.03 | $38.49M | |
-2.59 | $8.46M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemogenyx Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hemogenyx Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hemogenyx Pharmaceuticals Plc's PE Ratio?
How is the PE Ratio calculated for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
What is the highest PE Ratio for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
What is the 3-year average PE Ratio for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
What is the 5-year average PE Ratio for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
How does the current PE Ratio for Hemogenyx Pharmaceuticals Plc (HEMO.L) compare to its historical average?